Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

• Liyang Zhang,
• John A. Zuris,
• Ramya Viswanathan,
• Jasmine N. Edelstein,
• Rolf Turk,
• Bernice Thommandru,
• H. Tomas Rube,
• Steve E. Glenn,
• Michael A. Collingwood,
• Nicole M. Bode,
• Sarah F. Beaudoin,
• Swarali Lele,
• Sean N. Scott,
• Kevin M. Wasko,
• Steven Sexton,
• Christopher M. Borges,
• Mollie S. Schubert,
• Gavin L. Kurgan,
• Matthew S. McNeill,
• Cecilia A. Fernandez,
• Vic E. Myer,
• Richard A. Morgan,
• Mark A. Behlke,
• Christopher A. Vakulskas

Affiliations

Liyang Zhang

Integrated DNA Technologies, Inc

John A. Zuris

Editas Medicine Inc

Ramya Viswanathan

Editas Medicine Inc

Jasmine N. Edelstein

Editas Medicine Inc

Rolf Turk

Integrated DNA Technologies, Inc

Bernice Thommandru

Integrated DNA Technologies, Inc

H. Tomas Rube

University of California - Merced

Steve E. Glenn

Integrated DNA Technologies, Inc

Michael A. Collingwood

Integrated DNA Technologies, Inc

Nicole M. Bode

Integrated DNA Technologies, Inc

Sarah F. Beaudoin

Integrated DNA Technologies, Inc

Swarali Lele

Editas Medicine Inc

Sean N. Scott

Editas Medicine Inc

Kevin M. Wasko

Editas Medicine Inc

Steven Sexton

Editas Medicine Inc

Christopher M. Borges

Editas Medicine Inc

Mollie S. Schubert

Integrated DNA Technologies, Inc

Gavin L. Kurgan

Integrated DNA Technologies, Inc

Matthew S. McNeill

Integrated DNA Technologies, Inc

Cecilia A. Fernandez

Editas Medicine Inc

Vic E. Myer

Editas Medicine Inc

Richard A. Morgan

Editas Medicine Inc

Mark A. Behlke

Integrated DNA Technologies, Inc

Christopher A. Vakulskas

Integrated DNA Technologies, Inc